Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study-Reference-Cited by-同舟云学术

Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study

Published:2016-03 Issue:1 Volume:21 Page:10-14
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripher Nerv Syst

Author:

Iancu Ferfoglia Ruxandra¹²,Guimarães-Costa Raquel¹,Viala Karine³,Musset Lucile⁴,Neil Jean⁴,Marin Benoit⁵⁶⁷,Léger Jean-Marc¹

Affiliation:

1. Department of Neurology, National Referral Center for Rare Neuromuscular Diseases; University Hospital Pitié-Salpêtrière and University Paris VI; Paris France

2. Department of Neurology; Geneva University Hospitals; Geneva Switzerland

3. Department of Neurophysiology; University Hospital Pitié-Salpêtrière and University Paris VI; Paris France

4. Department of Immunology, Laboratory of Immunochemistry & Autoimmunity; University Hospital Pitié-Salpêtrière and University Paris VI; Paris France

5. Centre d'Epidémiologie de Biostatistique et de Méthodologie de la Recherche; CHU Limoges; Limoges France

6. Tropical Neuroepidemiology; INSERM, U1094; Limoges France

7. Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology; Limoges France

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jns.12156/fullpdf

Reference15 articles.

1. Long-term effect of rituximab in anti-MAG polyneuropathy;Benedetti;Neurology,2008

2. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases;Chassande;Muscle Nerve,1998

3. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy;Dalakas;Ann Neurol,2009

4. Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy;Gruson;J Peripher Nerv Syst,2011

5. Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients;Hospital;Hematologica,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab with alkylating agent in anti‐myelin‐associated glycoprotein neuropathy: A retrospective study of 26 cases;British Journal of Haematology;2024-03-18

2. Paraproteinemia‐associated neuropathy with or without anti‐myelin‐associated glycoprotein antibody;Clinical and Experimental Neuroimmunology;2024-02-26

3. Prevalence and clinical profiles of anti‐myelin‐associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients;European Journal of Neurology;2024-02-20

4. Immunochemotherapy versus rituximab in anti‐myelin‐associated glycoprotein neuropathy: A report of 64 patients;British Journal of Haematology;2022-04-14

5. Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy;Neurology - Neuroimmunology Neuroinflammation;2021-11-10